Literature DB >> 25726927

Single nucleotide polymorphism array profiling identifies distinct chromosomal aberration patterns across colorectal adenomas and carcinomas.

Peter Zarzour1, Lies Boelen, Fabio Luciani, Dominik Beck, Anuratha Sakthianandeswaren, Dmitri Mouradov, Oliver M Sieber, Nicholas J Hawkins, Luke B Hesson, Robyn L Ward, Jason W H Wong.   

Abstract

The progression of benign colorectal adenomas into cancer is associated with the accumulation of chromosomal aberrations. Even though patterns and frequencies of chromosomal aberrations have been well established in colorectal carcinomas, corresponding patterns of aberrations in adenomas are less well documented. The aim of this study was to profile chromosomal aberrations across colorectal adenomas and carcinomas to provide a better insight into key changes during tumor initiation and progression. Single nucleotide polymorphism array analysis was performed on 216 colorectal tumor/normal matched pairs, comprising 60 adenomas and 156 carcinomas. While many chromosomal aberrations were specific to carcinomas, those with the highest frequency in carcinomas (amplification of chromosome 7, 13q, and 20q; deletion of 17p and chromosome 18; LOH of 1p, chromosome 4, 5q, 8p, 17p, chromosome 18, and 20p) were also identified in adenomas. Hierarchical clustering using chromosomal aberrations revealed three distinct subtypes. Interestingly, these subtypes were only partially dependent on tumor staging. A cluster of colorectal cancer patients with frequent chromosomal deletions had the least favorable prognosis, and a number of adenomas (n = 9) were also present in the cluster suggesting that, at least in some tumors, the chromosomal aberration pattern is determined at a very early stage of tumor formation. Finally, analysis of LOH events revealed that copy-neutral/gain LOH (CN/G-LOH) is frequent (>10%) in carcinomas at 5q, 11q, 15q, 17p, chromosome 18, 20p, and 22q. Deletion of the corresponding region is sometimes present in adenomas, suggesting that LOH at these loci may play an important role in tumor initiation.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 25726927     DOI: 10.1002/gcc.22243

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

Review 1.  The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy.

Authors:  Ha Thi Nguyen; Hong-Quan Duong
Journal:  Oncol Lett       Date:  2018-05-09       Impact factor: 2.967

2.  Patterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer.

Authors:  Keyvan Torabi; Rosa Miró; Nora Fernández-Jiménez; Isabel Quintanilla; Laia Ramos; Esther Prat; Javier del Rey; Núria Pujol; J Keith Killian; Paul S Meltzer; Pedro Luis Fernández; Thomas Ried; Juan José Lozano; Jordi Camps; Immaculada Ponsa
Journal:  Carcinogenesis       Date:  2015-08-04       Impact factor: 4.944

3.  Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients.

Authors:  Donatella Conconi; Serena Redaelli; Giorgio Bovo; Biagio Eugenio Leone; Emanuela Filippi; Luciana Ambrosiani; Maria Grazia Cerrito; Emanuela Grassilli; Roberto Giovannoni; Leda Dalprà; Marialuisa Lavitrano
Journal:  Tumour Biol       Date:  2016-08-02

4.  Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.

Authors:  Yuta Kouyama; Takaaki Masuda; Atsushi Fujii; Yushi Ogawa; Kuniaki Sato; Taro Tobo; Hiroaki Wakiyama; Yukihiro Yoshikawa; Miwa Noda; Yusuke Tsuruda; Yousuke Kuroda; Hidetoshi Eguchi; Fumio Ishida; Shin-Ei Kudo; Koshi Mimori
Journal:  Cancer Sci       Date:  2019-08-29       Impact factor: 6.716

Review 5.  The Roles of Transmembrane Mucins Located on Chromosome 7q22.1 in Colorectal Cancer.

Authors:  Hussain Almasmoum
Journal:  Cancer Manag Res       Date:  2021-04-14       Impact factor: 3.989

6.  Isoform-specific effects of transcription factor TCFL5 on the pluripotency-related genes SOX2 and KLF4 in colorectal cancer development.

Authors:  Javier Galán-Martínez; Konstantinos Stamatakis; Inés Sánchez-Gómez; Silvia Vázquez-Cuesta; Núria Gironés; Manuel Fresno
Journal:  Mol Oncol       Date:  2021-10-08       Impact factor: 7.449

7.  Quantitative analysis of somatically acquired and constitutive uniparental disomy in gastrointestinal cancers.

Authors:  Keyvan Torabi; Pau Erola; Maria Isabel Alvarez-Mora; Marcos Díaz-Gay; Queralt Ferrer; Antoni Castells; Sergi Castellví-Bel; Montserrat Milà; Juan José Lozano; Rosa Miró; Thomas Ried; Immaculada Ponsa; Jordi Camps
Journal:  Int J Cancer       Date:  2018-12-03       Impact factor: 7.396

8.  GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.

Authors:  Sho Nambara; Takaaki Masuda; Yuta Kobayashi; Kuniaki Sato; Taro Tobo; Kensuke Koike; Miwa Noda; Yushi Ogawa; Yousuke Kuroda; Shuhei Ito; Hidetoshi Eguchi; Keishi Sugimachi; Koshi Mimori
Journal:  Cancer Sci       Date:  2019-12-27       Impact factor: 6.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.